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INTRODUCTION
The skin and its accessory structures in several respects may be considered as expressing
secondary sexual characteristics. Examples found in many levels of animal life include the
sexual plumage of birds, sex differences in hair texture in the laboratory rat, the mane of the
male lion, the "sexual skin" of many of the sub-human primate females, and the typical
regional arrangement of hair on the human body characteristic of each sex. It would seem
reasonable to assume that these conditions are determined fundamentally by the sex hor-
mones. Yet hormone therapy aimed at the control of human hair has not yet been satis-
factory. It is well, however, to cite examples of the hormonal stimulation of hair as well as
certain attempts to inhibit its growth by endocrine therapy.
Certain neoplasms that exert generalized masculinizing influences on the female often
produce profound changes in the type and distribution of hair. Evidence exists that these
changes are wrought by means of steroid hormones. Some, but not all, tumors of adrenal-
cortical origin, and the arrhenoblastoma of the ovary effect virilism in women with its ac-
companying male hair patterns.
Male hormone therapy in the practice of gynecology usually results in various degrees of
virilism if the treatment is heavy or prolonged. Hypertrichosis is only one of the several
undesirable conditions that may occur.
Experimentally, Whitaker (1) found an increase in the growth of hair on the chest and
abdomen of three male subjects resulting from the topical application of testosterone. The
increase, as high as 100%, appeared first in areas that carry a heavy growth in the more hir-
sute individual. This condition has persisted for over four years in one subject, after only
five months of treatment.
Inhibition of hair growth in animals by the use of female hormones has been reported.
Gardner and DeVita (2) found that massive doses of estradiol benzoate given subcu-
taneously to dogs prevented the regrowth of hair on shaved areas. Similar treatment of
rats caused a generalized decrease in the hair coat according to Hooker and Pfeiffer (3).
Williams, Gardner, and DeVita (4) reported that topical application of small amounts of
estrone to shaved areas of the skin of dogs inhibited the replacement of hair. Application
of estrone to a limited portion of the suprapubic region of a male subject resulted
in shedding of the hair which was not replaced completely two years later (5).
In spite of all the evidence for the hormonal influence on hair, only a few successful at-
tempts to reduce facial hypertrichosis in women have been reported. Peters (6) reported
some success by the use of estriol given orally. Dorf (7) found slight, if any, benefit by the
percutaneous use of an estrogen. Mussio-Fournier, et al (8) found definitely beneficial
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results in 60 of 100 cases treated percutaneously with estradiol benzoate in a vehicle of lano-
lin, vaseline and water. Results appeared as early as two months after beginning the treat-
ment and increased with continued therapy. The hypertrichosis was accompanied by men-
strual irregularities in most of the patients treated. From the same laboratory (9) it was
reported that intradermal injections of estradiol diproprionate were also effective in the
reduction of facial hair of a young woman with accompanying menstrual irregularities.
One of the authors (F. J. S.) observed a striking remission of a severe facial hypertrieho-
sis in a young woman while being treated by a topical application of estrone in alcohol. No
subsequent observations have been possible. Another (W. W.) noticed in a controlled ex-
periment that estrone in alcohol causes a reduced amount of facial hair after two months
treatment. The opposite side of the face receiving alcohol only showed no change. Sub-
sequent attempts to repeat this therapy on two other subjects were not so successful.
With the hope of learning more about the relation of female hormones to facial hyper-
trichosis, two separate experiments were carried out employing larger numbers of patients.
EXPERIMENTAL
A. Using Estrone in Alcohol on Severely Hirsute Subjects.
—Whitaker, Stoddard, and Goforth
Method. Twenty-five hospitalized women were selected because of their
severe facial hypertrichosis. Initial records of the general body distribution of
hair were made and photographs of the face were taken in order to furnish an
accurate record of the hirsutism. The ages of the patients ranged between 24 and
70 with approximately one-third in the menopausal or post-menopausal state.
No marked menstrual irregularities existed among the others. Their physical
health was fair to good. With few exceptions they were cooperative and were,
in general, hopeful of results though they were told that this was a trial of new
treatments and no benefits could be promised.
Material. The vehicle was 50% ethyl alcohol to which artificial color and scent
were added. One cubic centimeter contained 0.1 mg. estrone (1000 I.U.).
Gloved attendants rubbed this solution onto the right side of the face with
emphasis on certain designated areas twice daily for four months. The exact
amount used was not determinable, but the average was about 1800 LU. daily
per p.tient. Alcohol was similarly rubbed onto the left side of the face. Neither
the subjects nor the attendants knew which solution contained the hormone.
Resu its. A slight decrease in the hairiness on the right side of the face of a few
patients was suggested by examination of all subjects during the fifth week of
treatment. More significantly the subjects or attendants offered the same ob-
servations. However, at the end of four months no differences could be seen be-
tween the two sides of the face. One patient experienced moderate interruptions
of her menstrual cycles.
B. Using Estrone and Estradiol6 on Young Patients
with Moderate Hyperirichosis or Acne Vulgaris.
—Whitaker and Grekin
Method and Materials. Nineteen first year student nurses were used, all of
whom had a mild to moderate degree of facial hirsutism. They were selected
from among those coming to a Dermatology clinic seeking relief from hypertri-
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chosis. This group was felt to be an ideal one for observation because of its con-
tinued association with the University Hospital and oniy those students who gave
promise of faithful cooperation were chosen. The subjects were in the early adult
group ranging in age from 18 to 23 years with one exception, a student of 27.
Ten of the group also suffered from acne vulgaris varying from mild to moderately
severe in type and it was therefore decided to observe the effects of the hormonal
therapy on this disease also. Accordingly four other students in the same age
group with moderate cases of acne vulgaris but no hypertrichosis were added to
the study. One of the patients with excess hair also had a seborrheic dermatitis
of the face. Prior to therapy, records of the general hirsute pattern were made,
photographs of the face were taken in most cases and a careful history of the
menses was obtained. When acne was present, any relationship of the process
to the menstrual cycle and the duration of the disease was noted. All of the
patients were in good health and enthusiastic about the treatment so that co-
operation for the most part was excellent. Menstrual periods were normal. The
following two preparations were employed: estrone in a concentration of 1 mgm
per gram of vehicle and alpha estradiol in a concentration of 0.4 mgm per gram.
The vehicle was an oil in water emulsion used instead of alcohol in an attempt to
obtain a more prolonged contact with the skin. Since it was developed for a face
cream it was not unpleasant to use.
Of the total of 23 patients studied, ten were treated with estrone preparation
on the right side of the face and the blank vehicle used as a control on the left
side, (two of these with acne only), nine were treated with the alpha estradiol
preparation on the right side of the face and the control on the left (two with acne
only) and four were treated with the estrone on the right side and the estradiol
on the left side of the face. The preparations were identical in appearance and
the patients were told that two different materials were being used to determine
the more effective one. In no instance did the patient know a control was being
employed. Since all the patients were attending nursing school daily, the only
practical time that the medication could be used was at bedtime and it was
necessary that each student apply it herself. Careful individual instruction as
to the mode of application was given. The cream was to be massaged into the
face for a minimum of three minutes each evening using only the right hand for
rubbin.g the right side of the face and the left hand for the left side to avoid any
mixture of the preparations. The medication was dispensed in 30 gram con-
tainers to be used up in three to four weeks which insured monthly observations
when the patients returned for additional medication.
Results. The average period of treatment was four months with monthly ob-
servation in all cases. Nine patients were followed for only three months and no
patients continued therapy for longer than six months. Of the 19 cases with
hypertrichosis one girl, age 18, in whom the appearance of excess facial hair was
of recent origin continued to have progression of the process so that after four
months of faithful treatment she had more hair than at the onset. In the re-
Prepared by Dr. E. L. Cataline of the College of Pharmacy, University of Michigan.
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maining 18 cases no change at any time was noted in the amount or character of
the hair either objectively or by the subjects themselves. The symmetrical
distribution was unaffected by the unilateral use of the medication.
A total of 14 cases of acne vulgaris was observed. Case 2 wa that of a 20 year
old girl with mild hypertrichosis and a moderate number of pustules, papules and
comedones over the cheeks and chin. She used the estradiol cream on the right
cheek and chin and the control on the left. After one month of therapy definite
improvement was noted by the patient and ourselves over the right face with none
on the left. However, after the second month the improvement was bilaterally
equal and thereafter no further change occurred although she continued to use the
medication for 3 additional months. In case 5, of a girl, aged 23, who had a
moderate acne of the face, chest and back and a moderate amount of facial hair,
estrone was applied to the right side of the face and the control to the left. After
two months' treatment, there was slight bilateral improvement in the acne but
this did not persist. She was treated for a total of four months.
In case 6, a girl, aged 18, with a moderately severe acne of the face was treated
with estradiol and the control. After two months of therapy, bilateral recession
of the acne was observed but this was more pronounced over the left (control)
side of the face. In the following two months no further improvement occurred.
In case 0, a 21 year old girl used estrone and a control. She also had some bi-
lateral improvement after one month but showed no further change in the four
succeeding months.
None of the changes noted were marked and all were within the normal vari-
ation usually seen in acne-form eruptions. No demonstrable changes were noted
in the remaining ten patients with acne.
In the one case of seborrheic dermatitis (case 15) estradiol and the control were
used. The eruption healed bilaterally in three months, remaining clear there-
after, although the excess facial hair was unaffected.
Other reactions which might be attributed to the hormonal therapy were ob-
served in two of the subjects. In case 3, a girl, aged 21, had had her menarche
at the age of 13 and since that time her menses had been regular and normal with-
out dysemenorrhea. Following three months of treatment with the estradiol
cream, her menstrual period occurred eight days late and was accompanied by
severe menstrual cramps. Therapy was discontinued and the symptoms did not
recur. In case 10, a 23 year old student gave a history of mild dysmejiorrhea
occurring only on the first day of her period since the menarche at age 14. After
applying estradiol for three months, she reported a marked increase in dys-
menorrhea with prolongation of the cramps over a three day period. In this
patient, we also noted a peculiar granular change in the skin which appeared in
the area where the estradiol had been used.
DISCUSSION
Reconciliation of these apparently conflicting results is difficult. It is not
likely that spontaneous remission of hypertrichosis occurred in those successful
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studies and uniformly failed in the experiments reported in this paper. Other
variables to be considered are: the estrogen used, its route of administration and
dosage, the vehicles employed, and the selection of the patients. Beneficial re-
suits have followed the oral use of estriol (6), estradiol applied percutaneously
(8) and intradermally (9). Negative results are reported here for the use of
estrone and estradiol by topical application. Thus, no reason is at present
evident for ascribing the variance of results to the estrogen used or to the route
of administration.
It is not easy to compare dosages used because they are not clearly stated, but
those used by Mussio-Fournier and by Don were sufficient to produce systemic
effectiveness even when applied to the skin, as indicated by improvements in the
menstrual irregularities. Likewise estrone in alcohol in experiment A and
estradiol in a face cream of experiment B were of such dosage that one or two of
the subjects experienced some alteration of menstruation that may b attributed
to the therapy. Neither clinical studies on human patients nor the animal ex-
periments (2, 3, 4) strongly suggests that the difference in the results is due to the
dosage of the estrogen.
There is no doubt that the vehicle employed in the application of medicaments
to the skin is important, but present data seem insufficient to explain the discrep-
ancies on these grounds. Estradiol applied to the skin showed evidence of
systemic effectiveness when applied in a lanolin-vaseline-water base (8) and when
applied in a face cream, showing that both are effective carriers of the hormone,
but the results on hair growth were contradictory.
It is possible that the selection of patients may have a bearing on the results.
The subjects of experiment A were chosen for a relatively severe hirsutism and a
wide range of ages. None with notable menstrual disturbances was included.
The subjects of experiment B were young, with moderate hypertrichosis and with
no irregularities of menstruation. In contrast, most of the subjects of Mussio-
Fournier, of Dorf and of Peters presented histories of menstrual complaints.
Menstrual irregularities as well as other stated symptoms suggest the presence of
ovarian deficiency as a common cause. Don's finding that anterior pituitary
gonadotropic hormone was the most potent inhibitor of hirsutism while reducing
other symptoms of ovarian inadequacy gives further support to this view.
The attractive hypothesis presents itself that hypertrichosis in some subjects
is merely one of several symptoms of ovarian depression, relievable by estrogenic
therapy, and that the apparently similar hirsutism in others with normal function
of the reproductive organs may be due to other causes. Since the latter con-
dition exists in spite of normal endogenous ovarian hormones it is not likely to
respond readily to exogenous estrogens. However, even though this hypothesis
may seem reasonable on the basis of the above observations, it is obviously in-
adequate, because it does not explain the results of animal experiments nor give
much aid in understanding the ultimate chemical control of the activities of the
hair follicle.
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SUMMARY AND CONCLUSIONS
1. Twenty-five severely hirsute hospitalized patients of middle age and above
were treated for four months by the percutaneous application of estrone in
alcohol.
2. Nineteen young women with normal menstrual histories were treated for
facial hypertrichosis for from three to six months by the topical application of
estradiol or estrone in a face cream.
3. Comparison of the side of the face treated with the opposite side of the face
which received the vehicle only showed no change in the facial hair as a result of
the therapy. Nor was there indication of improvement of acne present in some
of the young subjects.
4. A discussion of the apparent discrepancy between these results and those of
other investigators is included.
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